Need professional-grade analysis? Visit stockanalysis.com
$5.22B
17.69
969
N/A
Hangzhou Alltest Biotech Co. Ltd. A (688606) trades on SHG in CNY. The company is classified in the Healthcare sector under the Medical Instruments & Supplies industry. The stock currently trades at CNY57.41, down 6.19% from the previous close.
Over the past year, 688606 has traded between a low of CNY57.41 and a high of CNY76.53. The stock has lost 11.2% over this period. It is currently 25.0% below its 52-week high.
Hangzhou Alltest Biotech Co. Ltd. A has a market capitalization of $5.22B, with a price-to-earnings ratio of 17.69.
Hangzhou Alltest Biotech Co., Ltd. engages in the research, development, production, and sale of in vitro diagnostic reagents in China and internationally. The company offers rapid diagnostic reagents, including drug and drug abuse, infectious disease, women's health, tumor marker, and cardiac marker testing products. Its products include COVID-19 antigen and antibody tests; veterinary tests; fluorescence immunoassay tests and analyzers; urine analysis solutions, biochemistry reagents, VTM, blood glucose monitoring systems, and HB hemoglobin test meters. In addition, the company offers SARS-COV-2 RT-qPCR assays, virus specimen stabilizers, and viral DNA/RNA extraction kits; and other test products. Its products are used in clinical testing, on-site testing, personal health management, and other fields. Hangzhou Alltest Biotech Co., Ltd. was founded in 2009 and is based in Hangzhou, China.
Side-by-side comparison against top Healthcare peers.